close
close
Tecan publishes Agenda for the Annual General Meeting 2025 | 18.03.25

Tecan publishes Agenda for the Annual General Meeting 2025 | 18.03.25

Tecan publishes Agenda for the Annual General Meeting 2025

  • The Board of Directors will propose the re -election of current seven members
  • Karen Huebscher will not stand for re -election
  • Myra Eskes, Christburg Christburg and Daniel R. Marshak proposed for re -election to the Compensation Committee
  • Non -financial matters report presented for approval for the first time with an audit certificate
  • Proposal for a stable CHF 3.00 dividend per action, reflecting
    Cash flows solid and continuous positive commercial perspectives

Männedorf, Switzerland, March 18, 2025 – The Tancan Group (Six Swiss Exchange: Tecn) published today the agenda of the annual general meeting on April 10, 2025.

Karen Huebscher, who served as a member of the Board of Directors since 2012, has decided not to defend re -election. Lukas Braunschweiler, president of the Board of Directors, commented:
«I would like to express my gratitude to Karen Huebscher, also in the name of the entire Board of Directors, for its dedicated service years and the valuable contributions it made to the growth and development of Tencan.

All the other current members of the Board of Directors will be proposed to the shareholders for re -election for a period of one year: Myra Eskes, Oliver Fetzer, Matthias Gillner, Christist Kreuzburg, Monica Manotas, Daniel R. Marshak and Lukas Braunschweiler as president.

The Board of Directors proposes the re -election of Myra Eskes, Christburg and Daniel R. Marshak to the Compensation Committee. Subject to his re -election, it is planned that Myra Eskes will take over the president of the Kreuzburg Christburg Compensation Committee. Oliver Fetzer will not continue as a member of the Committee.

Sustainability reports developed plus
For the second time, a report on non -financial matters will be submitted to the TECAN shareholders for approval at the annual general meeting this year. This report, published as part of Annual 2024 report on March 12, 2025, was submitted to a limited guarantee audit of Ernst & Young AG, Zurich, for the first time, focusing on selected indicators. The audit certificate marks an important step in the progress of the Sustainability Reports of TECAN, ensuring additional transparency and commitment.

Proposal for a stable dividend
Based on solid cash flows for the whole year 2024 and on the basis of a current positive commercial perspective, the Board of Directors will propose a dividend without CHF 3.00 changes per action. Half of the dividend, that is, Chf 1.50, will pay again from the available capital contribution reserve and, therefore, is not subject to tax withholding.

Key key dates

  • A qualitative update Q1 on May 12, 2025 will be published.
  • The provisional report of 2025 will be published on August 12, 2025.
  • A qualitative update of the third quarter will be published on October 13, 2025.

About Tecan
Tecan (www.tecan.com) Improves people’s lives and health by empowering customers to climb the worldwide health innovation of the science of life to the clinic. Tancan is a pioneer and world leader in laboratory automation. As an original team manufacturer (OEM), TECAN is also a leader in the development and manufacture of OEM instruments, components and medical devices that are then distributed by associated companies. Founded in Switzerland in 1980, the company has 3,300 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and services network in more than 70 countries. In 2024, Tancan generated Sales from Chf 934 million (USD 1,062 million; EUR 984 million). The registered actions of Tecan Group are negotiated at the Exchange Swiss (Tec; ISIN CH0012100191).

For more information:

Tean Group
Martin Brändle
Senior vice president, corporate communications and go
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
[email protected]

www.tecan.com



Back To Top